Versartis, Inc. (VSAR)

Analysts 8
Positive
25%
Median target $4 (50% upside)


    • 09/25/17
      Citigroup
      neutral
      $3
    • 09/22/17
      Bank of America Merrill Lynch
      neutral
    • 09/22/17
      Cantor Fitzgerald
      overweight
      $14
      "Although we believe these pivotal [Phase 3 VELOCITY] data are insufficient to support approval we..."
      View details
    • 09/22/17
      SunTrust
      hold
      $4
    • 09/22/17
      Cowen
      market perform
      $3
    • 09/22/17
      Canaccord Genuity
      buy
      $9
    • 09/22/17
      Piper Jaffray
      neutral
      $4
    • 09/22/17
      Barclays
      underweight
      $4
    • 12/20/16
      Credit Suisse
      outperform
      $20
      "Pivotal results from Phase 3 VELOCITY trial expected in 3Q 2017 and will be the main catalyst for..."
      View details
    • 08/13/15
      Morgan Stanley
      equal weight
      $17
    • 04/23/14
      Zacks
      hold
    • 25% positive
      $4 Median

    Users who viewed VSAR also viewed

    more

    Best rated stocks last 7 days

    more

    Most rated stocks last 72 hrs

    more